Nivolumab/Ipilimumab Bests Nivolumab in Ovarian and Extra-Renal Clear Cell Carcinomas
The combination of nivolumab and ipilimumab improved responses as well as survival outcomes in patients with ovarian or gynecologic clear cell carcinomas.
Stay updated with breaking news from Pelvic Malignancies Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The combination of nivolumab and ipilimumab improved responses as well as survival outcomes in patients with ovarian or gynecologic clear cell carcinomas.
Don S. Dizon, MD, FACP, FASCO, discusses future directions for precision medicine approaches in ovarian cancer.
Don S. Dizon, MD, on the prevalence of sexual complications in patients with breast cancer.
Five oncologists explored the challenges of caring for patients with cancer and how they deal with their complex feelings when a patient dies.
There are many factors that affect our ability to be healthy, but we unfortunately do not all face the same barriers to accessing care. Such roadblocks can be related to cost, discrimination, location, sexual orientation, and gender identity, to name just a few.